Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Serebruany

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
The American Journal of Cardiology|July 11, 2006
Dose of aspirin and bleeding risksVictor Serebruany
The New England Journal of Medicine|March 21, 2008
Prasugrel versus clopidogrelVictor Serebruany
Ebiomedicine|July 19, 2016
Oral Anticoagulants and Renal Impairment: The Convoluting DilemmaVictor Serebruany
Current Medical Research and Opinion|September 30, 2006
Comment and reply on: the dose of aspirin for the prevention of cardiovascular and cerebrovascular eventsVictor Serebruany
The New England Journal of Medicine|May 12, 2006
NXY-059 for acute ischemic strokeVictor Serebruany
Circulation. Cardiovascular Quality and Outcomes|May 16, 2013
Prasugrel: the real-life perspectiveVictor Serebruany, Dan Atar
Nature Reviews. Cardiology|August 11, 2017
Antiplatelet therapy: Aspirin in the elderly - tailored approaches ahead?Victor Serebruany, Elena Golukhova
International Journal of Cardiology|April 30, 2016
Missed bleeding events after ticagrelor in PEGASUS trial: Massive non-compliance, information censoring, or both?Victor Serebruany, Ales Tomek
Thrombosis and Haemostasis|April 8, 2009
Clopidogrel and proton pump inhibitors: gastric protection at expense of vascular benefit?Victor Serebruany, Shinya Goto
Drugs of Today (Barcelona, Spain : 1998)|April 4, 2009
Prasugrel for arterial coronary thrombosisVictor Serebruany, Leonid Makarov
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
The American Journal of Cardiology|July 11, 2006
Dose of aspirin and bleeding risksVictor Serebruany
The New England Journal of Medicine|March 21, 2008
Prasugrel versus clopidogrelVictor Serebruany
Ebiomedicine|July 19, 2016
Oral Anticoagulants and Renal Impairment: The Convoluting DilemmaVictor Serebruany
Current Medical Research and Opinion|September 30, 2006
Comment and reply on: the dose of aspirin for the prevention of cardiovascular and cerebrovascular eventsVictor Serebruany
The New England Journal of Medicine|May 12, 2006
NXY-059 for acute ischemic strokeVictor Serebruany
Circulation. Cardiovascular Quality and Outcomes|May 16, 2013
Prasugrel: the real-life perspectiveVictor Serebruany, Dan Atar
Nature Reviews. Cardiology|August 11, 2017
Antiplatelet therapy: Aspirin in the elderly - tailored approaches ahead?Victor Serebruany, Elena Golukhova
International Journal of Cardiology|April 30, 2016
Missed bleeding events after ticagrelor in PEGASUS trial: Massive non-compliance, information censoring, or both?Victor Serebruany, Ales Tomek
Thrombosis and Haemostasis|April 8, 2009
Clopidogrel and proton pump inhibitors: gastric protection at expense of vascular benefit?Victor Serebruany, Shinya Goto
Drugs of Today (Barcelona, Spain : 1998)|April 4, 2009
Prasugrel for arterial coronary thrombosisVictor Serebruany, Leonid Makarov
Pageof 11